2 completed, 1 terminated, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Anthracyclines: new trials by email Literature Review of Anthracyclines trials Research Report on Anthracyclines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) Pulsed electromagnetic fields (PEMFs), Device: Pulsed electromagnetic fields (PEMFs); Drug: Anthracycline OR Taxane - Breast Cancer | Phase 1 | Completed | National University Hospital, Singapore | 14 | 2022-12-30 | 2026-03-13 |
| HDM201 Added to CT in R/R or Newly Diagnosed AML HDM201, cytarabine, anthracycline - Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2019-11-15 | 2020-01-09 | |
| Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173) Pembrolizumab, Nab-paclitaxel, Anthracycline (doxorubicin) - Triple Negative Breast Neoplasms | Phase 1 | Completed | Merck Sharp & Dohme LLC | 60 | 2016-01-27 | 2020-09-10 |
| A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer Olaparib, Carboplatin, Anthracycline - Breast Cancer | Phase 1 | Terminated | AstraZeneca | 15 | 2015-11-06 | 2019-02-20 |
Breast Neoplasms (2) · Leukemia, Myeloid, Acute (1) · Neoplasm, Residual (1) · Parkinson Disease 4, Autosomal Dominant Lewy Body (1) · Triple Negative Breast Neoplasms (1)
AstraZeneca (1) · Merck Sharp & Dohme LLC (1) · National University Hospital, Singapore (1) · Novartis Pharmaceuticals (1)
Singapore (1) · Spain (1) · United States (1)
Judith Balmana (1) · Rachel Wong, Medical Degree (1) · Tiffany Traina (1)
PMID 32278621, PMID 32450725, PMID 40069763
2015 (1), 2018 (1)